|Table of Contents|

Chinese expert consensus on the diagnosis and treatment of endometrial cancer in the elderly

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2024 23
Page:
4413-4424
Research Field:
Publishing date:

Info

Title:
Chinese expert consensus on the diagnosis and treatment of endometrial cancer in the elderly
Author(s):
LIU Tingting1KONG Weimin1GAO Guolan2CHEN Aiping3GAO Jun4
Gynecology Branch of the Chinese Society of Gerontology and Geriatrics (1.Beijing Obstetrics and Gynecology Hospital Affiliated to Capital Medical University,Beijing Maternal and Child Health Hospital,Beijing 100006,China;2.West China Second Hospital,Sichuan University,Sichuan Chengdu 610016,China;3.Affiliated Hospital of Qingdao University,Shandong Qingdao 266000,China;4.Jiangxi Cancer Hospital,Jiangxi Nanchang 330006,China.)
Keywords:
endometrial cancerelderly womenChinaexpert consensus
PACS:
R737.33
DOI:
10.3969/j.issn.1672-4992.2024.23.001
Abstract:
Endometrial cancer is one of the most common gynecological malignancies.As the aging population continues to increase,China's population structure will move from mild aging to moderate aging,and the number of elderly patients with endometrial cancer will increase year by year.Since the disease characteristics and prognosis of endometrial cancer in the elderly are different from those in young and middle-aged patients,and elderly patients have many comorbidities and limited tolerance to various treatments,treatment measures should have their own particularities.However,there is currently a lack of relevant guidelines and expert consensus,and there is an urgent need to issue guidance specifically for the diagnosis and treatment of endometrial cancer in the elderly.Therefore,the Gynecology Branch of the Chinese Society of Gerontology and Geriatrics organized experts to form the following expert consensus on the diagnosis and treatment of endometrial cancer in elderly Chinese women based on evidence-based medicine and combined with clinical diagnosis and treatment experience,aiming to standardize the diagnosis and treatment decisions of endometrial cancer in elderly Chinese women and guide clinical practice.

References:

[1]SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2]CROSBIE EJ,KITSON SJ,MCALPINE JN,et al.Endometrial cancer[J].Lancet,2022,399(10333):1412-1428.
[3]ISLAMI F,WARD EM,SUNG H,et al.Annual report to the nation on the status of cancer,part 1:National Cancer Statistics[J].J Natl Cancer Inst,2021,113(12):1648-1669.
[4]国家统计局.第七次全国人口普查公报[Z/OL].(2021-05-11)[2021-12-10].http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818824.html. National Bureau of Statistics.Communiqué of the Seventh National Population Census[Z/OL].(2021-05-11)[2021-12-10].http://www.stats.gov.cn/tjsj/tjgb/rkpcgb/qgrkpcgb/202106/t20210628_1818824.html.
[5]盛亦男,顾大男.概率人口预测方法及其应用—《世界人口展望》概率人口预测方法简介[J].人口学刊,2020,42(5):31-46. SHENG YN,GU DN.Probabilistic population forecasting methods and their applications-introduction to probabilistic population forecasting methods in《World Population Prospects》[J].Population Journal,2020,42(5):31-46.
[6]RICHARD R BARAKAT.妇科肿瘤学原理与实践[M].林种秋,李晶,译.5版.北京:人民卫生出版社,2012:760-762. RICHARD R BARAKAT.Principles and practice of gynecological oncology[M].LIN ZQ,LI J,translate.5th edition.Beijing:People's Health Publishing House,2012:760-762.
[7]HAG-YAHIA N,GEMER O,EITAN R,et al.Age is an independent predictor of outcome in endometrial cancer patients:An Israeli Gynecology Oncology Group cohort study[J].Acta Obstet Gynecol Scand,2021,100(3):444-452.
[8]赵文荣,程静新.老年子宫内膜癌的诊疗策略[ J].实用妇产科杂志,2019,35(8):567-570. ZHAO WR,CHENG JX.Diagnosis and treatment strategies for elderly endometrial cancer[J].Journal of Practical Obstetrics and Gynecology,2019,35(8):567-570.
[9]冯妙肖,桑秀波,陈说,等.子宫内膜癌的预后因素分析[ J].解剖科学进展,2016,22(1):35-38. FENG MX,SANG XB,CHEN S,et al.Analysis of prognosis factors in endometrial carcinoma[J].Progress of Anatomical Sciences,2016,22(1):35-38.
[10]National Comprehensive Cancer Network.NCCN clinical practice guidelines in oncology:Uterine Neoplasms.version.1.2024[EB/OL].2024,MS1-MS36[2024-5-1].https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1473.
[11]AUNE D,NAVARRO ROSENBLATT DA,CHAN DS,et al.Anthropometric factors and endometrial cancer risk:A systematic review and dose-response meta-analysis of prospective studies[J].Ann Oncol,2015,26:1635-1648.
[12]闫慧敏,张梅,张笑,等.中国老年人代谢综合征流行特征及其影响因素研究[J].中华流行病学杂志,2019,40(3):284-289. YAN HM,ZHANG M,ZHANG X,et al.Study of epidemiological characteristics of metabolic syndrome and influencing factors in elderly people in China[J].Clin J Epidemiol,2019,40(3):284-289.
[13]王芬芬,谢幸.子宫内膜癌的病因及高危因素[J].实用妇产科杂志,2020,36(6):401-403. WANG FF,XIE X.The etiology and high-risk factors of endometrial cancer[J].Journal of Practical Obstetrics and Gynecology,2020,36(6):401-403.
[14]YU K,HUANG ZY,XU XL,et al.Estrogen receptor function:Impact on the human endometrium[J].Front Endocrinol(Lausanne),2022,13:827724.
[15]DOMINGUEZ-VALENTIN M,SAMPSON JR,SEPPL TT,et al.Cancer risks by gene,age,and gender in 6350 carriers of pathogenic mismatch repair variants:findings from the Prospective Lynch Syndrome Database[J].Genet Med,2020,22:15-25.
[16]DE JONGE MM,DE KROON CD,JENNER DJ,et al.Endometrial cancer risk in women with germline BRCA1 or BRCA2 mutations:Multicenter cohort study[J].J Natl Cancer Inst,2021,113:1203-1211.
[17]GREDMARK T,KVINT S,HAVEL G,et al.Histopathological findings in women with postmenopausal bleeding[J].Br J Obstet Gynaecol,1995,102:133-136.
[18]谢玲玲,林荣春,林仲秋.国际权威子宫内膜癌诊治指南解读[J].实用妇产科杂志,2020,36(06):428-432. XIE LL,LIN RC,LIN ZQ.Interpretation of International Authoritative Guidelines for Diagnosis and Treatment of Endometrial Cancer[J].Journal of Practical Obstetrics and Gynecology,2020,36(06):428-432.
[19]李小毛,叶辉霞,杨晓辉,等.60岁以上子宫内膜癌临床病理分析[J].现代妇产科进展,2015,24(05):354-356. LI XM,YE HX,YANG XH,et al.Clinical and pathological analysis of endometrial cancer over 60 years old[J].Prog Obstet Gynecol,2015,24(05):354-356.
[20]KANDOTH C,SCHULTZ N,CHERNIACK AD,et al.Integrated genomic characterization of endometrial carcinoma[J].Nature,2013,497(7447):67-73.
[21]中国研究型医院学会妇产科学专业委员会.子宫内膜癌分子分型临床应用中国专家共识(2024年版)[J].中国实用妇科与产科杂志,2024,40(6):638-644. Chinese Research Hospital Association Obstetrics and Gynecology Professional Committee.Chinese Expert Consensus on Clinical Application of Molecular Typing of Endometrial Cancer(2024 Edition)[J].Chinese Journal of Practical Gynecology and Obstetrics,2024,40(6):638-644.
[22]孙丽丽,刘格丹,贾楠,等.不同分子分型的子宫内膜癌临床病理特征分析[J].肿瘤预防与治疗,2022,35(5):435-441. SUN LL,LIU GD,JIA N,et al.Clinicopathological features of endometrial cancer with different molecular types[J].J Cancer Control Treat,2022,35(5):435-441.
[23]李晶,林仲秋.子宫内膜癌癌症基因组图谱分子分型对临床诊断、预后判断及术后处理的影响[J].中国实用妇科与产科杂志,2023,39(11):1080-1086. LI J,LIN ZQ.The impact of molecular typing of endometrial cancer genomic map on clinical diagnosis,prognosis,and postoperative management[J].Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1080-1086.
[24]聂禹菲,郭红燕,高妍,等.子宫内膜癌分子分型与肥胖及代谢异常合并症的关系[J].实用妇产科杂志,2022,38(7):555-558. NIE YF,GUO HY,GAO Y,et al.The relationship between molecular subtypes of endometrial cancer and comorbidities of obesity and metabolic abnormalities[J].Journal of Practical Obstetrics and Gynecology,2022,38(7):555-558.
[25]俞梅,向阳,马晓欣,等.子宫内膜癌筛查规范化建议[J].中华妇产科杂志,2020,55(05):307-311. YU M,XIANG Y,MA XX,et al.Suggestions for Standardization of Endometrial Cancer Screening[J].Chinese Journal of Obstetrics and Gynecology,2020,55(05):307-311.
[26]杨红.子宫内膜癌筛查策略[J].中国实用妇科与产科杂志,2023,39(11):1062-1065. YANG H.Screening strategy for endometrial cancer[J].Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1062-1065.
[27]KOSKAS M,AMANT F,MIRZA MR,et al.Cancer of the corpus uteri:2021 update[J].Int J Gynaecol Obstet,2021(Suppl 1):45-60.
[28]中国医师协会微创医学专业委员会妇科肿瘤学组,中国医院协会妇产医院分会妇科肿瘤专业学组,中国优生科学协会肿瘤生殖学分会.子宫内膜浆液性癌诊治的中国专家共识(2022年版)[J].癌症进展,2022,20(9):865-874,879. The Gynecological Oncology Group of the Minimally Invasive Medicine Professional Committee of the Chinese Medical Association,the Gynecological Oncology Professional Group of the Obstetrics and Gynecology Hospital Branch of the Chinese Hospital Association,and the Tumor Reproduction Branch of the Chinese Eugenics Association.Chinese Expert Consensus on the Diagnosis and Treatment of Endometrial Serous Cancer(2022 Edition)[J].Cancer Progression,2022,20(9):865-874,879.
[29]SUNDAR S,BALEGA J,CROSBIE E,et al.BGCS uterine cancer guidelines:Recommendations for practice[J].Eur J Obstet Gynecol Reprod Biol,2017,213:71-97.
[30]中华人民共和国国家卫生健康委员会.子宫内膜癌诊治规范(2018年版)[J].肿瘤综合治疗电子杂志,2020,6(4):25-35. National Health Commission of the People's Republic of China.Guidelines for Diagnosis and Treatment of Endometrial Cancer(2018 Edition)[J].Journal of Comprehensive Cancer Therapy,2020,6(4):25-35.
[31]HEFLER L,LAFLEUR J,KICKMAIER S,et al.Risk of endometrial cancer in asymptomatic postmenopausal patients with thickened endometrium:Data from the FAME-Endo study:An observational register study[J].Arch Gynecol Obstet,2018,298(4):813-820.
[32]徐茜茜,周群英.绝经后无症状子宫内膜增厚女性临床病理特征分析[J].中国计划生育学杂志,2022,30(8):1911-1914,1919. XU QQ,ZHOU QY.Clinical and pathological characteristics analysis of asymptomatic endometrial thickening in postmenopausal women[J].Chinese Journal of Family Planning,2022,30(8):1911-1914,1919.
[33]National Comprehensive Cancer Network.NCCN Guidelines Older Adult Oncology.Version1.2024[EB/OL].[2024-5-1].https://www.nccn.org/professionals/physician_gls/pdf/older_adult.pdf.
[34]陈锐,程静新.老年妇科肿瘤患者决策途径及综合评估指南要点解读[J].实用妇产科杂志,2019,35(8):581-583. CHEN R,CHENG JX.Interpretation of decision-making pathways and comprehensive evaluation guidelines for elderly gynecological cancer patients[J].Journal of Practical Obstetrics and Gynecology,2019,35(8):581-583.
[35]MOHANTY S,ROSENTHAL RA,RUSSELL MM,et al.Optimal Perioperative Management of the Geriatric Patient:A Best Practices Guideline from the American College of Surgeons NSQIP and the American Geriatrics Society[J].J Am Coll Surg,2016,222(5):930-947.
[36]朱鸣雷,黄宇光,刘晓红,等.老年患者围手术期管理北京协和医院专家共识[J].协和医学杂志,2018,9(1):36-41. ZHU ML,HUANG YG,LIU XH,et al.Expert Consensus on Perioperative Management of Elderly Patients at Peking Union Medical College Hospital[J].Medical Journal of Peking Union Medical College Hospital,2018,9(1):36-41.
[37]朱欣,张瑜.老年妇科肿瘤患者围手术期管理及手术加速康复[J].实用妇产科杂志,2019,35(8):576-577. ZHU X,ZHANG Y.Perioperative management and accelerated recovery of elderly gynecological cancer patients[J].Journal of Practical Obstetrics and Gynecology,2019,35(8):576-577.
[38]HORNOR MA,MA M,ZHOU L,et al.Enhancing the American College of Surgeons NSQIP Surgical Risk Calculator to predict geriatric outcomes[J].J Am Coll Surg,2020,230:88-100.
[39]ZHOU L,GUO F,LI D,et al.Short-and long-term outcomes of laparoscopic surgery for elderly patients with clinical stage I endometrial cancer[J].J BUON,2020,25(2):764-771.
[40]CORRADO G,VIZZA E,PERRONE AM,et al.Comparison between laparoscopic and robotic surgery in elderly patients with endometrial cancer:A retrospective multicentric study[J].Front Oncol,2021,11:724886.
[41]DE BOER SM,POWELL ME,MILESHKIN L,et al.Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer(PORTEC-3):Patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial[J].Lancet Oncol,2019,20:1273-1285.
[42]MILLER DS,FILIACI VL,MANNEL RS,et al.Carboplatin and paclitaxel for advanced endometrial cancer:Final overall survival and adverse event analysis of a phase Ⅲ trial(NRG Oncology/GOG0209)[J].J Clin Oncol,2020,38:3841-3850.
[43]林雨璇,王元景,孔为民.2023年美国放射肿瘤学会子宫内膜癌放射治疗临床实践指南解读[J].中国临床医生杂志,2023,51(11):1284-1289. LIN YX,WANG YJ,KONG WM.Interpretation of the 2023 American Society of Radiation Oncology Clinical Practice Guidelines for Radiotherapy for Endometrial Cancer[J].Chinese Journal of Clinical Physicians,2023,51(11):1284-1289.
[44]HARKENRIDER MM,ABU-RUSTUM N,ALBUQUERQUE K,et al.Radiation therapy for endometrial cancer:An American society for radiation oncology clinical practice guideline[J].Pract Radiat Oncol,2023,13(1):41-65.
[45]MEIXNER E,LANG K,KNIG L,et al.Postoperative radiotherapy for endometrial cancer in elderly(≥80 years) patients:Oncologic outcomes,toxicity,and validation of prognostic scores[J].Cancers(Basel),2021,13(24):6264.
[46]刘绍颖,范典,郑博豪,等.子宫内膜癌靶向治疗新进展与前沿展望[J].中国癌症防治杂志,2021,13(2):121-125. LIU SY,FAN D,ZHENG BH,et al.New progress and frontier prospects of targeted therapy for endometrial cancer[J].Clin J of Oncol Prev and Treat,2021,13(2):121-125.
[47]谢玲玲,林仲秋.《2024 NCCN子宫肿瘤临床实践指南(第1版)》解读[J].中国实用妇科与产科杂志,2023,39(11):1122-1127. XIE LL,LIN ZQ.Interpretation of the 2024 NCCN Clinical Practice Guidelines for Uterine Tumors(First Edition)[J].Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1122-1127.
[48]刘川,李秀琴.晚期/复发子宫内膜癌的免疫靶向治疗[J].中国实用妇科与产科杂志,2023,39(11):1095-1098. LIU C,LI XQ.Immunotherapy and targeted therapy for advanced/recurrent endometrial carcinoma[J].Chinese Journal of Practical Gynecology and Obstetrics,2023,39(11):1095-1098.
[49]YANG F,MARKOVIC SN,MOLINA JR,et al.Association of sex,age,and Eastern Cooperative Oncology Group Performance Status with survival benefit of cancer immunotherapy in randomized clinical trials:A systematic review and Meta-analysis[J].JAMA Netw Open,2020,3:e2012534.
[50]田红艳.子宫内膜癌的中医证型与预后关系研究[J].现代中医药,2018,38(6):40-43. TIAN HY.Research on the relationship between traditional Chinese Medicine syndrome types and prognosis of endometrial cancer[J].Modern Traditional Chinese Medicine,2018,38(6):40-43.
[51]夏华敏,蒋士卿.蒋士卿治疗子宫内膜癌经验浅析[J].中国民间疗法,2022,28(6):18-19. XIA HM,JIANG SQ.Analysis of Jiang Shiqing's experience in treating endometrial cancer[J].China's Naturopathy,2022,28(6):18-19.
[52]黄杰特,洪金妮,胡闽湘,等.中药注射剂在子宫内膜癌辅助治疗中的临床应用[J].中国民间疗法,2022,30(16):113-115. HUANG JT,HONG JN,HU MX,et al.Clinical application of traditional Chinese Medicine injection in adjuvant treatment of endometrial cancer[J].China's Naturopathy,2022,30(16):113-115.
[53]中国抗癌协会肿瘤营养专业委员会.子宫内膜癌患者的营养治疗专家共识[J].肿瘤代谢与营养电子杂志,2020,7(4):415-417. Chinses Society of Nutritional Oncology.Expert Consensus on Nutritional Therapy for Patients with Endometrial Cancer[J].Electron J Metab Nutr Cancer,2020,7(4):415-417.

Memo

Memo:
-
Last Update: 2024-11-01